Literature DB >> 7127259

Defect in assimilation following combined radiation and chemotherapy in patients with locally unresectable pancreatic carcinoma.

J S Barkin, M H Kalser, S Thomsen, D Redlhammer.   

Abstract

The relative contributions of high-dose irradiation and/or chemotherapy to the nutritional problems of patients with inoperable pancreatic carcinoma were evaluated by study of pancreatic exocrine function and jejunal function and morphologic findings in ten patients before and after treatment. Nutrient assimilation studies included determination of serum carotene levels, D-xylose absorption and fat absorption. Crosby capsule biopsy specimen of jejunal mucosa were evaluated with light microscopy. Fat assimilation was the only parameter of nutritional function to significantly worsen after therapy. Low serum carotene levels present in the patients before therapy remained low but did not significantly change after treatment. D-xylose absorption and the morphologic structure of the jejunal mucosa were normal before and after treatment. These findings support the previous observations that the nutritional problems of the patient with inoperable pancreatic carcinoma are due to pancreatic insufficiency and that high dose irradiation and chemotherapy can exacerbate the pancreatic insufficiency but do not produce jejunal dysfunction. Therefore, it is suggested that pancreatic exocrine replacement therapy may improve the nutritional status of these patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127259     DOI: 10.1002/1097-0142(19821115)50:10<2189::aid-cncr2820501035>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  1 in total

1.  Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.

Authors:  Jodie A Barkin; Amy Westermann; William Hoos; Cassadie Moravek; Lynn Matrisian; Hongwei Wang; Lynn Shemanski; Jamie S Barkin; Lola Rahib
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.